Correlation Between Veracyte and Syndax Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Veracyte and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Veracyte and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Veracyte and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Syndax Pharmaceuticals.

Diversification Opportunities for Veracyte and Syndax Pharmaceuticals

0.77

Correlation Coefficient

Veracyte  Syndax Pharmaceuticals

Poor diversification

The 3 months correlation between Veracyte and Syndax is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Veracyte i.e., Veracyte and Syndax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Veracyte and Syndax Pharmaceuticals

Given the investment horizon of 90 days Veracyte is expected to generate 1.1 times more return on investment than Syndax Pharmaceuticals. However, Veracyte is 1.1 times more volatile than Syndax Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.11 per unit of risk. If you would invest  3,186  in Veracyte on September 11, 2025 and sell it today you would earn a total of  1,147  from holding Veracyte or generate 36.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Veracyte  vs.  Syndax Pharmaceuticals

Veracyte

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.

Syndax Pharmaceuticals

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Syndax Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Syndax Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Veracyte and Syndax Pharmaceuticals

The main advantage of trading using opposite Veracyte and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.

The idea behind Veracyte and Syndax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.